• Home
  • About EVM
  • Hot Topics
  • Key Topics
    • Access to new vaccines
  • EVM Initiatives
    • Influenza
    • External Affairs
    • Regulatory & Scientific Affairs
    • Access to vaccines
    • Others Initiatives
  • Publications
    • EVM Briefings Sheets
    • EVM Surveys
    • Facts & Figures
  • Press Room
    • In the Press
    • Vaccine News
  • Events
  • Diseases & Vaccines
    • About Vaccines
    • EU Regulatory Framework for Vaccines
    • Preventable Diseases
  • Useful Links
    • All sites by alphabetical order
    • All sites by category

SEARCH:

Newsletter:

EFPIA/EVM
Rue du Trône 108B /
Troonstraat 108B
1050 Brussels - BELGIUM
info@evm-vaccines.org

Home

EVM is a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the European pharmaceutical industry.

Formed in 1991 to improve public health through immunization and promoting R&D of innovative vaccines, EVM represents major European vaccine producers accounting for the majority of the vaccines used worldwide.

EVM Members are dedicated to improve public health through immunization and to promote R&D of innovative vaccines.

>> More about EVM

top

NEWS

29th Annual Meeting of the European Society for Paediatrics Infectious Diseases (ESPID) - Workshop on Translating vaccination policies to practice : challenges, pitfalls and solutions - EVM presentation "How academia and industry can contribute to the promise of current and new vaccines" - The Hague, 9 June 2011


EVM welcomes EU Health Ministers action to boost cooperation in the fight against infectious childhood diseases - 6 June 2011


The EVM adopted a White Paper on the implementation of the EU Paediatric Regulation and its Impact on Vaccine Development.


The EVM replied to the EC consultation on the modernization of public procurement rules.

bottom
top

Hot Topics

bottom
© European Vaccine Manufacturers (EVM) - a specialised group of EFPIA 2009 | Developpement par Site-Com